I personally dont have an issue with how long the trial is - given how thorough NEU was with PhII.
Also - I trust that ACADIA and Neuren are aware of the length and results required to progress, as its in their financial interests.
Onwards and upwards !
Ann: Plans for Phase 3 trial in Rett syndrome, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.04 |
Change
-0.500(3.99%) |
Mkt cap ! $1.559B | |||
| Open | High | Low | Value | Volume |
| $12.45 | $12.45 | $11.88 | $1.226M | 101.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 121 | $12.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.04 | 507 | 3 |
View Market Depth
| Last trade - 10.28am 23/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |